The following represents disclosure information provided by authors of this abstract. The ASCO Scientific Program Committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered self-held and compensated unless otherwise noted. Employment/Leadership relationships are considered compensated employment unless otherwise noted. L = Leadership, U = Uncompensated, I = Immediate Family Member, B = Both Myself and Immediate Family Member, Inst = My Institution
Validated biomarker signatures that predict pathologic response to preoperative chemoradiation therapy (CTRT) with high specificity and desirable sensitivity levels in patients with esophageal cancer (EC).
J. A. Ajani
No relevant relationships to disclose
X. Wang
No relevant relationships to disclose
Y. Hayashi
No relevant relationships to disclose
D. Maru
No relevant relationships to disclose
J. Welsh
No relevant relationships to disclose
W. L. Hofstetter
No relevant relationships to disclose
J. H. Lee
No relevant relationships to disclose
M. S. Bhutani
No relevant relationships to disclose
A. Suzuki
No relevant relationships to disclose
D. A. Berry
No relevant relationships to disclose
J. Izzo
No relevant relationships to disclose